drugset / Trial / NCT00459940

The Effects of TZD on Fat Metabolism and Insulin Sensitivity in GH-Replaced GHD Patients

NCT00459940

Completed 20 enrolled University of Aarhus
RandomizedParallel-groupDouble-blindTreatment

Summary

In the present double blind, placebo-controlled, parallel study we evaluated the impact of 12 weeks thiazolidinedione (TZD) administration on basal and insulin-stimulated substrate metabolism in growth hormone-replaced adults with growth hormone deficiency.

Timeline

Start
2004-09
Primary completion
Completion
2006-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Pioglitazone Small molecule

Indications